1-Nitroso-1,2,3,4-tetrahydrochinaldin | 27328-22-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 1-Nitroso-1,2,3,4-tetrahydrochinaldin
• 英文别名: 2-methyl-1-nitroso-1,2,3,4-tetrahydro-quinoline, N-nitroso-dl-tetrahydro-quinaldine；2-Methyl-1-nitroso-1,2,3,4-tetrahydro-chinolin, N-Nitroso-dl-tetrahydro-chinaldin；Nitrosotetrahydroquinaldine；2-methyl-1-nitroso-3,4-dihydro-2H-quinoline
• CAS: 27328-22-9
• 化学式: C₁₀H₁₂N₂O
• 分子量: 176.218
• InChiKey: OEBVRKUMBRZZQY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  13
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  32.7
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  1-Nitroso-1,2,3,4-tetrahydrochinaldin 在 四氯化钛 、 magnesium 作用下， 以 乙醚 、 1,2-二氯乙烷 为溶剂， 反应 0.5h， 以83%的产率得到2-methyl-1,2,3,4-tetrahydroquinolin-1-amine
  参考文献：
  名称：

  Landriani; Barlocco; Pinna, Il Farmaco, 1989, vol. 44, # 11, p. 1059 - 1068

  摘要：

  DOI：
• 作为产物：
  描述：

  1,2,3,4-四氢喹哪啶 在 盐酸 、 sodium nitrite 作用下， 以 水 、 乙腈 为溶剂， 反应 1.67h， 生成 1-Nitroso-1,2,3,4-tetrahydrochinaldin
  参考文献：
  名称：

  铑催化的N-亚硝基苯胺的串联酰基甲基化/亚砜基化与环己磺酸盐的合成，用于合成取代的吲唑N-氧化物。

  摘要：

  本文描述了一种原子经济的方案，可通过铑（III）催化的C–H活化和环化反应从易于获得的N-亚硝基苯胺和亚砜基鎓盐中合成吲唑N-氧化物。该方案采用亚硝基作为无痕的导向基团。该转化具有强大的反应活性，可耐受各种官能团，并在环境气氛下以中等至良好的产率进行，提供了一种直接的途径来获得结构多样且有价值的吲唑N-氧化物衍生物。重要的是，这种新的环化方法代表了迄今为止对N-亚硝基的未观察到的反应模式。

  DOI：

  10.1039/d0ob00723d

文献信息

• Co(III)-Catalyzed Coupling-Cyclization of Aryl C–H Bonds with α-Diazoketones Involving Wolff Rearrangement
  作者：Xinwei Hu、Xun Chen、Youxiang Shao、Haisheng Xie、Yuanfu Deng、Zhuofeng Ke、Huanfeng Jiang、Wei Zeng

  DOI：10.1021/acscatal.7b03668

  日期：2018.2.2

  cobalt(III)-catalyzed cross-coupling/cyclization of aryl C–H bonds of N-nitrosoanilines with α-diazo-β-ketoesters has been achieved. This protocol features a unique combination of Csp2-H activation/Wolff rearrangement process, allowing for the rapid assembly of quaternary 2-oxindoles. The empirical evidence and density functional theory (DFT) calculations reveal the trapping process of transient acceptor ketene

  N-亚硝基苯胺与α-重氮-β-酮酸酯的钴（III）催化的不寻常交叉偶联/环化反应已经实现。该协议具有Csp 2 -H激活/ Wolff重排过程的独特组合，可快速组装四级2-氧吲哚。经验证据和密度泛函理论（DFT）计算揭示了钴金属环对瞬态受体乙烯酮中间体的捕获过程。
• Synthesis, Structure-Activity Relationships, and Pharmacological Evaluation of Pyrrolo[3,2,1-ij]quinoline Derivatives: Potent Histamine and Platelet Activating Factor Antagonism and 5-Lipoxygenase Inhibitory Properties. Potential Therapeutic Application in Asthma
  作者：Dominique Paris、Michel Cottin、Patrice Demonchaux、Guy Augert、Pierre Dupassieux、Patrick Lenoir、Michael J. Peck、Daniel Jasserand

  DOI：10.1021/jm00004a013

  日期：1995.2

  A series of pyrrolo[3,2,1-ij]quinoline derivatives was synthesized and evaluated for their in vitro and in vivo activities against histamine, platelet activating factor (PAF), and leukotrienes which are recognized to be of importance in asthma. The structure-activity relationship studies have shown that the optimum moiety on the 1-position of the pyrroloquinoline nucleus is a 2-[4-(4-methyl-2-pyridinyl)-1-piperazinyl]ethyl chain in conjunction with a methyl group on the 2-position for potent antagonism of both histamine and PAF. The introduction of substituents on the 8- and 4-positions was also investigated in order to increase the potency of 5-lipoxygenase inhibition while retaining or improving the activities against histamine and PAF. This series is exemplified by 4-n-butyl-5,6-dihydro-8-hydroxy-2-methyl-1-[2-[4-(4-methyl- 2-pyridinyl)-1-piperazinyl]ethyl]-4H-pyrrolo[3,2,1-ij]quinoline (24, KC 11404) which was found to be active against all three of the selected mediators. Compound 24 was found to be orally active in guinea pig models against the histaminic phase of antigen-induced bronchospasm and PAF-induced bronchoconstriction (ED(50) = 1.9 and 2.1 mu mol/kg, respectively). When tested against the leukotriene-dependent phase of the antigen-induced bronchoconstriction, compound 24 showed the same potency as zileuton.